Endocyte Inc (NASDAQ:ECYT)

14.52
Delayed Data
As of Jun 18
 +0.16 / +1.11%
Today’s Change
1.17
Today|||52-Week Range
15.45
+239.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line5.5M-41.3M-43.9M-55.1M
 
 
 
 
 
Depreciation857.1K886.7K919.8K922.7K
 
 
 
 
 
Total Other Cash Flow9.6M8.3M9.7M20.7M
 
 
 
 
 
Funds From Operations16.0M-32.1M-33.3M-33.5M
 
 
 
 
 
Funds From/For Other Operating Expenses58.2M128.1K1.4M172.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-42.2M-32.2M-34.7M-33.7M
 
 
 
 
 
 
InvestingIncrease In Investments-149.4M-86.3M-139.9M-106.7M
 
 
 
 
 
Decrease In Investments82.3M88.1M190.8M134.9M
 
 
 
 
 
Capital Expenditures-1.5M-341.6K-713.8K-82.5K
 
 
 
 
 
Fixed Asset Disposal10.0K0.000.0015.7K
 
 
 
Other Investing - Uses0.000.000.00-12.8M
 
 
Net Cash Flow Investing-68.6M1.5M50.1M15.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale103.5M684.3K492.9K5.7M
 
 
 
 
 
Common Preferred Redeemed-3.8K-57.3K-164.5K-94.6K
 
 
 
 
 
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing103.5M627.0K328.5K5.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-38.8K-1.4K0.000.00
 
 
 
 
Net Change In Cash-7.3M-30.1M15.8M-12.7M